MCTA Charming Medical Limited

Fundamentals / CIK 0002035992 / USD

Charming Medical Limited reported $4.81M in revenue and a net loss of $23K for the fiscal year ended March 31, 2026 (down 22.7% year over year), with a 99.3% gross margin and a -0.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MCTA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2024 to 2026), reported in USD.

$6.13M$3.07M$0-$550KFY 2024 Revenue: $6.02MFY 2024 Net Income: $778K2024FY 2025 Revenue: $6.22MFY 2025 Net Income: $1.20M2025FY 2026 Revenue: $4.81MFY 2026 Net Income: -$23K2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31
Revenue $4.81M $6.22M $6.02M
Cost of Revenue $35K $16K $11K
Gross Profit $4.77M $6.21M $6.00M
Total Operating Expenses $4.84M $4.83M $5.01M
Operating Income -$29K $1.39M $1.01M
EBITDA $187K $1.65M $1.40M
Interest Income $73K $64K $20K
Interest Expense $16K $21K $26K
Income Before Tax $133K $1.44M $1.00M
Income Tax Expense $156K $236K $182K
Net Income -$23K $1.20M $778K
Basic EPS $0.00 $0.08 $0.05
Diluted EPS $0.00 $0.08 $0.05
Basic Shares Outstanding 16.2M 15.3M 15.3M
Diluted Shares Outstanding 16.2M 15.3M 15.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for MCTA.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31
Cash & Cash Equivalents $4.70M $817K
Cash & Short-Term Investments $4.70M $817K
Accounts Receivable, Net $201K $396K
Inventory $26K $27K
Total Current Assets $8.17M $3.37M
Property, Plant & Equipment, Net $607K $500K
Total Non-Current Assets $1.69M $1.99M
Total Assets $9.87M $5.36M
Accounts Payable $17K $3.5K
Short-Term Debt $186K $314K
Deferred Revenue (Current) $3.05M $3.46M
Other Current Liabilities $9.4K $215K
Total Current Liabilities $4.33M $4.95M
Total Non-Current Liabilities $356K $358K
Total Liabilities $4.69M $5.31M
Total Debt (incl. Leases) $908K $1.16M
Retained Earnings $97K $119K
Accumulated Other Comp. Income -$15K -$3.6K
Total Stockholders' Equity $5.18M $49K
Total Equity $5.18M $49K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-03-31
Cash & Cash Equivalents $4.70M $817K
Cash & Short-Term Investments $4.70M $817K
Accounts Receivable, Net $201K $396K
Inventory $26K $27K
Total Current Assets $8.17M $3.37M
Property, Plant & Equipment, Net $607K $500K
Total Non-Current Assets $1.69M $1.99M
Total Assets $9.87M $5.36M
Accounts Payable $17K $3.5K
Short-Term Debt $186K $314K
Deferred Revenue (Current) $3.05M $3.46M
Other Current Liabilities $9.4K $215K
Total Current Liabilities $4.33M $4.95M
Total Non-Current Liabilities $356K $358K
Total Liabilities $4.69M $5.31M
Total Debt (incl. Leases) $908K $1.16M
Retained Earnings $97K $119K
Accumulated Other Comp. Income -$15K -$3.6K
Total Stockholders' Equity $5.18M $49K
Total Equity $5.18M $49K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31
Net Income -$23K $1.20M $822K
Depreciation & Amortization $216K $263K $392K
Change in Receivables $194K -$44K -$165K
Change in Inventory $1.2K $1.4K $38K
Operating Cash Flow -$1.22M $426K $295K
Capital Expenditure -$340K -$288K -$211K
Free Cash Flow -$1.56M $138K $85K
Purchases of Investments -$11K -$501K --
Investing Cash Flow -$179K -$2.23M -$211K
Financing Cash Flow $5.29M $521K $100K
Net Change in Cash $3.90M -$1.28M $185K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for MCTA.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31
Gross Margin 99.3% 99.8% 99.8%
Operating Margin -0.6% 22.3% 16.8%
Net Profit Margin -0.5% 19.3% 12.9%
Return on Equity (ROE) -0.4% 2435.0% --
Return on Assets (ROA) -0.2% 22.4% --
Current Ratio 1.89x 0.68x --
Quick Ratio 1.88x 0.68x --
Debt to Equity 0.18x 23.57x --
Revenue Growth (YoY) -22.7% +3.4% --
Gross Profit Growth (YoY) -23.1% +3.4% --
Operating Income Growth (YoY) -102.1% +37.7% --
Net Income Growth (YoY) -101.9% +54.2% --
EPS Growth (YoY) -100.0% +60.0% --
Operating Cash Flow Growth (YoY) -385.5% +44.2% --
Free Cash Flow Growth (YoY) -1224.2% +63.1% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for MCTA.
Source: SEC EDGAR CompanyFacts (CIK 0002035992) · from March 31, 2024 Data through March 31, 2026 · synced Nov 20, 2026, 05:37 UTC · Open in terminal